Warning letter
Wockhardt Ltd: warning letter of Feb 21, 2006
FDA warning letter UCM075801 · Center for Drug Evaluation and Research
Key facts
| Reference number | UCM075801 |
|---|---|
| Company | Wockhardt Ltd |
| Subject | Current Good Manufacturing Practices/Active Pharmaceuticals Ingredient/Adulterated |
| Issue date | Feb 21, 2006 |
| Posted date | Feb 21, 2006 |
| Issuing office | Center for Drug Evaluation and Research |
| Product type | Drugs |
| CFR sections cited | 211.100, 211.188 |
| Country | 3 |
| Inspection city | Aurangabad |
| Inspection start date | Nov 8, 2005 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- VAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: